Author: foundationmedicineroche

NGS Test | Next Generation Sequencing

The Foundation Medicine comprehensive genomic profiling approach leverages next generation sequencing (NGS) test technology to examine regions of the tumour genome that other tests miss. It detects both novel and... Read More

Tissue Biopsy | Liquid Biopsy Test | Liquid Biopsy Testing

When Tissue Biopsy is not feasible, try FoundationOne®Liquid - Liquid Biopsy Test. It opens up the opportunity of comprehensive genomic profiling for solid tumour patients. Our FDA-approved liquid biopsy comprehensive genomic... Read More

Foundationone Testing | Liquid Biopsy Test | Liquid Biopsy Testing

Molecular Testing and Molecular Insights leader Foundation Medicine provides powerful insights to help personalise treatment strategies. The Foundation Medicine comprehensive genomic profiling approach broadly analyses the tumour genome to identify... Read More